These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7229726)

  • 21. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
    Parmentier C; Gardet P
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic roles of nuclear medicine].
    Bisson G; Chartrand R
    Union Med Can; 1990; 119(4):175-7. PubMed ID: 2201115
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of radioiodine treatment in childhood hyperthyroidism.
    Becker DV
    J Nucl Med; 1979 Aug; 20(8):890-4. PubMed ID: 396368
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyroid stunning in clinical practice: is it a real problem?
    Filesi M; Colandrea M; Montesano T; D'Apollo R; Ronga G
    Minerva Endocrinol; 2009 Mar; 34(1):29-36. PubMed ID: 19209126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of nuclear medicine to the therapy of malignant tumors.
    Feinendegen LE
    Strahlenther Onkol; 1991 Nov; 167(11):619-27. PubMed ID: 1962275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiobiologic basis for using 131I to treat patients with thyroid cancer].
    Suwiński R; Gawkowska-Suwińska M
    Wiad Lek; 2001; 54 Suppl 1():266-77. PubMed ID: 12182035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy-induced thyroid disorders.
    Jereczek-Fossa BA; Alterio D; Jassem J; Gibelli B; Tradati N; Orecchia R
    Cancer Treat Rev; 2004 Jun; 30(4):369-84. PubMed ID: 15145511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
    Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
    J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer induction in man from internal radioactivity.
    Mays CW
    Health Phys; 1973 Dec; 25(6):585-92. PubMed ID: 4593728
    [No Abstract]   [Full Text] [Related]  

  • 34. Estimation of cancer risks from radiotherapy of benign diseases.
    Trott KR; Kamprad F
    Strahlenther Onkol; 2006 Aug; 182(8):431-6. PubMed ID: 16896588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radiation-induced cancers following radiotherapy].
    Matsumoto Y; Sakai K
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):2015-20. PubMed ID: 10584565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
    Tubiana M
    Radiother Oncol; 2009 Apr; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer.
    Divgi C
    Semin Nucl Med; 2011 Sep; 41(5):369-73. PubMed ID: 21803187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear medicine in the management of thyroid disease.
    Buscombe J; Hirji H; Witney-Smith C
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1425-31. PubMed ID: 18759694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Secondary neoplasms in patients treated by chemotherapy and/or radiotherapy].
    Rytlewska M; Borkowski W
    Wiad Lek; 1983 Feb; 36(4):311-5. PubMed ID: 6344440
    [No Abstract]   [Full Text] [Related]  

  • 40. [Radiation and radiation exposure as risk factors in the formation of malignant neoplasms in man].
    Moskalev IuI; Strel'tsova VN; Vasilenko IIa
    Vopr Onkol; 1983; 29(3):95-106. PubMed ID: 6340349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.